4Cappelli C, Rotondi M, Pimla I, et al. TSH-Iowering effect of metformin in type 2 diabetic patients: differences between euthyroid, untreated hypothyroid, and euthyroid on L-T4 therapy patients. Diabetes Care, 2009, 32(9):1589-1590.
2Furlanetto TW, Peccin S, de O Schneider MA, et al. Prevalence of thyroid nodules in 40 years-old orold women. Rev Assoc Med Bras, 2000, 46: 331-334.
3Junik R, Kozinski M, Debska-Kozinska K. Thyroid ultrasound in diabetic patients without overt thyroid disease. Acta Radiol, 2006, 47:687-691.
4Semra A, Alptekin G, Altug K, et al. Metabolic syndrome and its components are associated with increased thyroid volume and nodule prevalence in a mild-to-moderate iodiue-deficient area. Eur J Endocrinol, 2009,161 .. 599-605.
5Rezzonico J, Rezzonico M, Pusiol E, et al. Introducing the thyroid gland as another victim of the insulin resistance syndrome. Thyroid, 2008, 18: 461-464.
6Rezz6nico J, Rezz6nico M, Pusiol E, et al. Metformin treatment for small benign thyroid nodules in patients with insulin resistance. Metab Syndr Relat Disord, 2011, 9:69-75.
7Kimura T, Van Keymeulen A, Golstein J, et al. Regulation of thyroid cell proliferation by TSH and other factors: a critical evaluation of in vitro models. Endocr Rev, 2001, 22:631-656.
8ZivaljevicV, Vlajinac H, Jankovic R, et al. Case-control study of anaplastic thyroid cancer. Tumori, 2004, 90:9-12.
